ASURAGEN
Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.
ASURAGEN
Industry:
Biotechnology Genetics Health Diagnostics Medical Oncology
Founded:
2006-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.asuragen.com
Total Employee:
251+
Status:
Active
Contact:
5126815201
Email Addresses:
[email protected]
Total Funding:
80 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content Facebook Sharer U.S. Server Location
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Invisible Sentinel
At Invisible Sentinel, we develop first in class, next generation technologies for a safer food supply.
Liquid Biotech
Liquid Biotech is a technology for cancer diagnostics and gene discover
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Growth Capital Fund
Growth Capital Fund investment in Series B - Asuragen
Telegraph Hill Partners
Telegraph Hill Partners investment in Series B - Asuragen
PTV Healthcare Capital
PTV Healthcare Capital investment in Series B - Asuragen
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Venture Round - Asuragen
Growth Capital Fund
Growth Capital Fund investment in Series A - Asuragen
Telegraph Hill Partners
Telegraph Hill Partners investment in Series A - Asuragen
Newest Events participated
Official Site Inspections
http://www.asuragen.com Semrush global rank: 6.78 M Semrush visits lastest month: 1.03 K
- Host name: a23-207-134-79.deploy.static.akamaitechnologies.com
- IP address: 23.207.134.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
